These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31326306)

  • 21. Systematic Review of the Long-Term Effects of Transgender Hormone Therapy on Bone Markers and Bone Mineral Density and Their Potential Effects in Implant Therapy.
    Delgado-Ruiz R; Swanson P; Romanos G
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31159456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort.
    Joseph T; Ting J; Butler G
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1077-1081. PubMed ID: 31472062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.
    Ruetsche AG; Kneubuehl R; Birkhaeuser MH; Lippuner K
    Osteoporos Int; 2005 Jul; 16(7):791-8. PubMed ID: 15502960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
    Stoffers IE; de Vries MC; Hannema SE
    J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total-body DXA.
    Blake GM; Herd RJ; Fogelman I
    Osteoporos Int; 1996; 6(6):462-70. PubMed ID: 9116392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total body and regional bone mineral densitometry (BMD) and soft tissue measurements: correlations of BMD parameter to lumbar spine and hip.
    Franck H; Munz M
    Calcif Tissue Int; 2000 Aug; 67(2):111-5. PubMed ID: 10920214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in grip strength in trans people and its association with lean body mass and bone density.
    Scharff M; Wiepjes CM; Klaver M; Schreiner T; T'Sjoen G; den Heijer M
    Endocr Connect; 2019 Jul; 8(7):1020-1028. PubMed ID: 31247588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone health of transgender adults: what the radiologist needs to know.
    Stowell JT; Garner HW; Herrmann S; Tilson K; Stanborough RO
    Skeletal Radiol; 2020 Oct; 49(10):1525-1537. PubMed ID: 32535772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
    Rehman Q; Lang T; Modin G; Lane NE
    Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The difference in spine specimen dual-energy X-ray absorptiometry bone mineral density between in situ and in vitro scans.
    Tan JS; Kayanja MM; St Clair SF
    Spine J; 2010 Sep; 10(9):784-8. PubMed ID: 20381430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of anthropometric parameters and bone size on bone mineral density using volumetric quantitative computed tomography and dual X-ray absorptiometry at the hip.
    Guglielmi G; van Kuijk C; Li J; Meta MD; Scillitani A; Lang TF
    Acta Radiol; 2006 Jul; 47(6):574-80. PubMed ID: 16875335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PREVALENCE AND TYPES OF GENDER-AFFIRMING SURGERY AMONG A SAMPLE OF TRANSGENDER ENDOCRINOLOGY PATIENTS PRIOR TO STATE EXPANSION OF INSURANCE COVERAGE.
    Kailas M; Lu HMS; Rothman EF; Safer JD
    Endocr Pract; 2017 Jul; 23(7):780-786. PubMed ID: 28448757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of dual-energy X-ray absorptiometry bone mineral measurement--comparison of a single-beam and fan-beam design: the effect of osteophytic calcification on spine bone mineral density.
    Franck H; Munz M; Scherrer M
    Calcif Tissue Int; 1995 Mar; 56(3):192-5. PubMed ID: 7750022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone health in transgender people: a narrative review.
    Giacomelli G; Meriggiola MC
    Ther Adv Endocrinol Metab; 2022; 13():20420188221099346. PubMed ID: 35651988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults.
    Iwamoto SJ; Rice JD; Moreau KL; Cornier MA; Wierman ME; Mancuso MP; Gebregzabheir A; Hammond DB; Rothman MS
    J Clin Transl Endocrinol; 2024 Jun; 36():100348. PubMed ID: 38756206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy.
    Sahota O; San P; Cawte SA; Pearson D; Hosking DJ
    Osteoporos Int; 2000; 11(1):52-8. PubMed ID: 10663359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
    Böttcher J; Pfeil A; Lehmann G; Heinrich B; Malich A; Hansch A; Petrovitch A; Mentzel HJ; Hein G; Kaiser WA
    Z Rheumatol; 2004 Dec; 63(6):473-82. PubMed ID: 15605213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-energy CT-based phantomless in vivo three-dimensional bone mineral density assessment of the lumbar spine.
    Wichmann JL; Booz C; Wesarg S; Kafchitsas K; Bauer RW; Kerl JM; Lehnert T; Vogl TJ; Khan MF
    Radiology; 2014 Jun; 271(3):778-84. PubMed ID: 24475863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy.
    Van Caenegem E; Taes Y; Wierckx K; Vandewalle S; Toye K; Kaufman JM; Schreiner T; Haraldsen I; T'Sjoen G
    Bone; 2013 May; 54(1):92-7. PubMed ID: 23369987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.